Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)


  • Traditional risk factors for dyslipidemia remain relevant to HIV-infected patients
    • These include older age, male sex, family history, poor diet, increased BMI, and sedentary lifestyle
  • All HIV-infected patients should have fasting lipids evaluated at entry to care and before ART initiation[Aberg 2014]
    • PIs and Dyslipidemia
        NRTIs and Dyslipidemia
          NNRTIs and Dyslipidemia
            Integrase Inhibitors, Maraviroc, and Dyslipidemia

            Action required